MEDICINES REVIEW
AS DR BRIAN MONTGOMERY’S REVIEW OF ACCESS TO NEW MEDICINES IS PUBLISHED, JOHN MACGILL ASKS DR MONTGOMERY ABOUT HIS FINDINGS…
MONTGOMERY’S REVIEW
IN EARLY 2016, FORMER GP AND NHS FIFE MEDICAL DIRECTOR, DR BRIAN MONTGOMERY, WAS ASKED BY THE SCOTTISH GOVERNMENT TO CONDUCT AN INDEPENDENT REVIEW OF ACCESS TO NEW MEDICINES IN SCOTLAND. 12 - SCOTTISH PHARMACIST
The Government published his report in December, with the Health Secretary saying his recommendations will now be taken forward.
Dr Montgomery had set out to answer two core questions. The first was whether the new approach adopted by Scottish Medicines Consortium (SMC) following a review in 2013 [see background far right] had led to an increase in access to end-of life, orphan and ultra-orphan medicines. The second question was how might systems and processes be improved further?
John Macgill (JM): Can you tell me about what you found while you were conducting your review?
Dr Brian Montgomery (BM): What I found was evidence that access had indeed increased. There are two different perspectives when measuring access for patients. We were seeing a mix of the impact of the new approach adopted by SMC and also the impact of Individual Patient Treatment Requests (IPTRs) processed by individual health boards.
I found that SMC did appear to be saying yes more frequently than previously and certainly, if you looked at it broadly across the three groups of medicines, the acceptance rate by SMC had gone up. However, if you then dug into that in a little more detail and you teased apart
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64
